ReviewTrends in cognitive sciences2013
Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.
Review in Trends in cognitive sciences, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 42 citations in OpenAlex.
- Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease.GeroScience · 2025Article
- Gintonin Binds to Reduced LPA4 Receptor Subtype in Human Cortical Neurons in Alzheimer's Disease Brains.Biomolecules · 2025Article
- Regular physical activity affects brain activities in old individuals: an observational study.PloS one · 2025Observational
- Free-water: A promising structural biomarker for cognitive decline in aging and mild cognitive impairment.Imaging neuroscience (Cambridge, Mass.) · 2024Article
- Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model.Translational neurodegeneration · 2022Article
- A missense variant in SHARPIN mediates Alzheimer's disease-specific brain damages.Translational psychiatry · 2021Article
- Metabolic disorder in Alzheimer's disease.Metabolic brain disease · 2021Review
- APOE-ε4 Shapes the Cerebral Organization in Cognitively Intact Individuals as Reflected by Structural Gray Matter Networks.Cerebral cortex (New York, N.Y. : 1991) · 2020Article
- Ginsenoside Compound K Induces Adult Hippocampal Proliferation and Survival of Newly Generated Cells in Young and Elderly Mice.Biomolecules · 2020Article
- CD8+ T Cell-Mediated Mechanisms Contribute to the Progression of Neurocognitive Impairment in Both Multiple Sclerosis and Alzheimer's Disease?Frontiers in immunology · 2020Review
- Association Between Earliest Amyloid Uptake and Functional Connectivity in Cognitively Unimpaired Elderly.Cerebral cortex (New York, N.Y. : 1991) · 2019Article
- Jowiseungchungtang Inhibits Amyloid-β Aggregation and Amyloid-β-Mediated Pathology in 5XFAD Mice.International journal of molecular sciences · 2018Article
- Neurocognitive Function after Cardiac Surgery: From Phenotypes to Mechanisms.Anesthesiology · 2018Review
- Predicting brain network changes in Alzheimer's disease with link prediction algorithms.Molecular bioSystems · 2017Article
- Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research.Cellular and molecular life sciences : CMLS · 2016Review
- Multistage Grading of Amnestic Mild Cognitive Impairment: The Associated Brain Gray Matter Volume and Cognitive Behavior Characterization.Frontiers in aging neuroscience · 2016Article
- Amyloid positron emission tomography and cognitive reserve.World journal of radiology · 2015Review
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2015Review
- Joint genetic analysis of hippocampal size in mouse and human identifies a novel gene linked to neurodegenerative disease.BMC genomics · 2014Article
- A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.Biological psychiatry · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Brain amyloid can be measured using positron emission tomography (PET). There are mixed reports regarding whether amyloid measures are correlated with measures of cognition (in particular memory), depending on the cohorts and cognitive domains assessed. In Alzheimer's disease (AD) patients and those at heightened risk for AD, cognitive performance may be related to the level and extent of classical AD pathology (amyloid plaques and neurofibrillary angles), but it is also influenced by neurodegeneration, neurocognitive reserve, and vascular health. We discuss what recent neuroimaging research has discovered about cognitive deficits in AD and offer suggestions for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.